Cargando…

Proteomic Analysis of Sera from Common Variable Immunodeficiency Patients Undergoing Replacement Intravenous Immunoglobulin Therapy

Common variable immunodeficiency is the most common form of symptomatic primary antibody failure in adults and children. Replacement immunoglobulin is the standard treatment of these patients. By using a differential proteomic approach based on 2D-DIGE, we examined serum samples from normal donors a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spadaro, Giuseppe, D'Orio, Concetta, Genovese, Arturo, Galeotafiore, Antonella, D'Ambrosio, Chiara, Di Giovanni, Stefano, Vitale, Monica, Capasso, Mario, Lamberti, Vincenzo, Scaloni, Andrea, Marone, Gianni, Zambrano, Nicola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180879/ https://www.ncbi.nlm.nih.gov/pubmed/21960740 http://dx.doi.org/10.1155/2011/706746

Ejemplares similares

Immunosuppressive therapy with rituximab in common variable immunodeficiency
por: Pecoraro, Antonio, et al.
Publicado: (2019)

Timing of infections in patients with primary immunodeficiencies treated with intravenous immunoglobulin (IVIg)
por: Gill, Parwinder K., et al.
Publicado: (2018)

Thymic Stromal Lymphopoietin Isoforms, Inflammatory Disorders, and Cancer
por: Varricchi, Gilda, et al.
Publicado: (2018)

Detection of Antibodies Against Human Leukocyte Antigen Class II in the Sera of Patients Receiving Intravenous Immunoglobulin
por: Takamatsu, Hiroyuki, et al.
Publicado: (2021)

Aseptic meningitis following intravenous immunoglobulin therapy of common variable immunodeficiency
por: Kaarthigeyan, K., et al.
Publicado: (2011)

Aseptic meningitis following intravenous immunoglobulin therapy of common variable immunodeficiency
por: Bhatt, Girish Chandra, et al.
Publicado: (2012)

Does Intravenous Immunoglobulin Therapy Prolong Immunodeficiency in Transient Hypogammaglobulinemia of Infancy?
por: Memmedova, Lale, et al.
Publicado: (2013)

Is It Safe to Switch From Intravenous Immunoglobulin to Subcutaneous Immunoglobulin in Patients With Common Variable Immunodeficiency and Autoimmune Thrombocytopenia?
por: Scheuerlein, Philipp, et al.
Publicado: (2018)

Hymenoptera Venom Immunotherapy: Tolerance and Efficacy of an Ultrarush Protocol versus a Rush and a Slow Conventional Protocol
por: Patella, Vincenzo, et al.
Publicado: (2012)

Review of intravenous immunoglobulin replacement therapy trials for primary humoral immunodeficiency patients
por: Schroeder, H. W., et al.
Publicado: (2012)

Is there a role for microbiome-based approach in common variable immunodeficiency?
por: Poto, Remo, et al.
Publicado: (2023)

Gut Microbiome and Common Variable Immunodeficiency: Few Certainties and Many Outstanding Questions
por: Varricchi, Gilda, et al.
Publicado: (2021)

Correction to: Is there a role for microbiome‑based approach in common variable immunodeficiency?
por: Poto, Remo, et al.
Publicado: (2023)

Elastic Stable Intramedullary Fixation Using Epibloc versus Crossed Kirschner Wires Fixation for Distal Forearm Fractures in Children: A Retrospective Analysis
por: De Vitis, Rocco, et al.
Publicado: (2022)

Implications to payers of switch from hospital-based intravenous immunoglobulin (IVIg) to home-based subcutaneous immunoglobulin (SCIg) therapy in patients with primary immunodeficiencies (PID) and secondary immunodeficiencies (SID) in Canada
por: Gerth, William C, et al.
Publicado: (2014)

Heterogeneity of Human Mast Cells With Respect to MRGPRX2 Receptor Expression and Function
por: Varricchi, Gilda, et al.
Publicado: (2019)

Superantigenic Activation of Human Cardiac Mast Cells
por: Varricchi, Gilda, et al.
Publicado: (2019)

Intravenous Immunoglobulin Monotherapy for Granulomatous Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency
por: Hasegawa, Mizue, et al.
Publicado: (2017)

Efficacy, Safety and Tolerability of a New 10% Intravenous Immunoglobulin for the Treatment of Primary Immunodeficiencies
por: Perez, Elena E., et al.
Publicado: (2021)

Implications to payers of switch from hospital-based intravenous immunoglobulin to home-based subcutaneous immunoglobulin therapy in patients with primary and secondary immunodeficiencies in Canada
por: Gerth, William C, et al.
Publicado: (2014)

Total and High Molecular Weight Adiponectin Expression Is Decreased in Patients with Common Variable Immunodeficiency: Correlation with Ig Replacement Therapy
por: Pecoraro, Antonio, et al.
Publicado: (2017)

INTERACTIONS OF THE COMPLEMENT SYSTEM WITH ENDOTOXIC LIPOPOLYSACCHARIDES IN IMMUNOGLOBULIN-DEFICIENT SERA
por: Gewurz, H., et al.
Publicado: (1970)

Trough Concentrations of Specific Antibodies in Primary Immunodeficiency Patients Receiving Intravenous Immunoglobulin Replacement Therapy
por: Hassin, Ori, et al.
Publicado: (2021)

Dispatcher-assisted telephone cardiopulmonary resuscitation using a French compression-only protocol: performance of volunteers with or without prior life support training
por: Ghuysen, A, et al.
Publicado: (2010)

High attack frequency in patients with angioedema due to C1-inhibitor deficiency is a major determinant in switching to home therapy: a real-life observational study
por: Squeglia, Veronica, et al.
Publicado: (2016)

Heterogeneity of Liver Disease in Common Variable Immunodeficiency Disorders
por: Pecoraro, Antonio, et al.
Publicado: (2020)

Human heart as a shock organ in anaphylaxis
por: Marone, Gianni, et al.
Publicado: (2014)

Cytokine dysregulation despite immunoglobulin replacement therapy in common variable immunodeficiency (CVID)
por: Poto, Remo, et al.
Publicado: (2023)

Efficiency of a French-language triage algorithm in the Emergency Department
por: Jobé, J, et al.
Publicado: (2011)

Belgian dispatchers' telephone cardiopulmonary resuscitation protocol training: an evaluation study
por: Ghuysen, A, et al.
Publicado: (2011)

Overcrowding estimation in the emergency department: is the simplest score the best?
por: Winkin, V, et al.
Publicado: (2013)

A fatal case of Perthes syndrome
por: Jobé, Jérôme, et al.
Publicado: (2013)

Reliability of a new French-language triage algorithm for out-of-hours primary care calls: the SALOMON rule
por: Brasseur, E, et al.
Publicado: (2015)

INTRAVENOUS IMMUNOGLOBULIN IN DERMATOLOGY
por: Dhar, Sandipan
Publicado: (2009)

Safety, Efficacy and Pharmacokinetics of a New 10% Liquid Intravenous Immunoglobulin (IVIG) in Patients with Primary Immunodeficiency
por: Wasserman, Richard L., et al.
Publicado: (2012)

Positive outcome in a patient with coronavirus disease 2019 and common variable immunodeficiency after intravenous immunoglobulin
por: Aljaberi, Rana, et al.
Publicado: (2020)

Efficacy and safety of human intravenous immunoglobulin 5% (Ig VENA) in pediatric patients affected by primary immunodeficiency
por: Ricci, Silvia, et al.
Publicado: (2020)

To see or not to see: does video CPR perform better than telephone CPR?
por: Ghuysen, A, et al.
Publicado: (2014)

Initial intravenous immunoglobulin doses should be based on adjusted body weight in obese patients with primary immunodeficiency disorders
por: Ameratunga, Rohan
Publicado: (2017)

Impact of Site of Care on Infection Rates Among Patients with Primary Immunodeficiency Diseases Receiving Intravenous Immunoglobulin Therapy
por: Wasserman, Richard L., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_u0pj9ua0omnc0qcutt0k01u87s